Corcept Therapeutics Inc. (CORT) Stock Price

CORTStock
$123.57+75.23%52W
Market Cap$13.36B
P/E121.06x
PEG Ratio0.81
Div yield
Beta0.42

CORT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)198.25%
Price vs S&P 500 (4W)27.79%
PEG Ratio0.81
VGM Score50.34
P/E Ratio (Annual)121.06x

CORT Earnings Surprise History

Q2 250.29est. 0.19
Q3 250.16est. 0.14
Q4 250.20est. 0.33
Q1 26-0.30est. -0.14
Q2 260.36est. 0.06

CORT Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.92
4.00
4.00
3.92

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
CORTCorcept Therapeutics Inc.
FCA$123.57
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Corcept Therapeutics Inc.

Corcept Therapeutics is a pharmaceutical company developing cortisol-modulating medications for metabolic, oncologic, and neuropsychiatric disorders. The company commercializes Korlym (mifepristone) for hypercortisolism (Cushing's syndrome), with a clinical-stage pipeline including compounds targeting multiple solid tumors, ALS, and MASH.